美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PELTHOS THERAPEUTICS INC

22.08

0.0000

成交量：917.00

成交額：2.03萬

市值：6,760.19萬

市盈率：-1.16

高：22.08

開：22.08

低：22.08

收：22.08

52周最高：54.29

52周最低：9.00

股本：306.17萬

流通股本：262.31萬

量比：0.42

換手率：0.03%

股息：- -

股息率：- -

每股收益(TTM):-19.0707

每股收益(LYR):-14.2710

淨資產收益率：-83.00%

總資產收益率：-20.64%

市淨率：1.16

市盈率(LYR):-1.55

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Pelthos Therapeutics公司孖展將用於支持Zelsuvmi商業化，並推動Xepi與Xeglyze上市

Pelthos Therapeutics Inc.盤中異動大幅上漲5.69%報29.00美元

Pelthos Therapeutics 簽署重要的藥品福利管理協議擴大患者對 Zelsuvmi™ (Berdazimer) 外用凝膠的獲取

佩爾索斯治療公司獲得Xepi乳膏在美國的獨家營銷權Pelthos Therapeutics Secures Exclusive U.S. Marketing Rights for Xepi Cream

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PTHS"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTHS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","market":"US","secType":"STK","nameCN":"PELTHOS THERAPEUTICS INC","latestPrice":22.08,"timestamp":1770737812515,"preClose":22.08,"halted":0,"volume":917,"delay":0,"changeRate":0,"floatShares":2623100,"shares":3061681,"eps":-19.070698,"marketStatus":"交易中","change":0,"latestTime":"02-10 11:22:42 EST","open":22.08,"high":22.08,"low":22.08,"amount":20277.3459,"amplitude":0,"askPrice":23.52,"askSize":33,"bidPrice":21.75,"bidSize":249,"shortable":3,"etf":0,"ttmEps":-19.070698,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"listingDate":1708059600000,"exchange":"AMEX","adjPreClose":22.08,"postHourTrading":{"tag":"盘后","latestPrice":22.08,"preClose":22.08,"latestTime":"16:48 EST","volume":4,"amount":88.24,"timestamp":1770673703627,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.418932},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","floatShares":2623100,"roa":"-20.64%","roe":"-83.00%","lyrEps":-14.271021,"volumeRatio":0.418932,"shares":3061681,"dividePrice":0,"high":22.08,"amplitude":0,"preClose":22.08,"low":22.08,"week52Low":9,"pbRate":"1.16","psRate":"9.13","week52High":54.29,"institutionHeld":0,"latestPrice":22.08,"committee":0.765957,"eps":-19.070698,"divideRate":0,"volume":917,"delay":0,"ttmEps":-19.070698,"open":22.08,"prevYearClose":31,"prevWeekClose":22.99,"prevMonthClose":24.02,"prevQuarterClose":31,"fiveDayClose":23.36,"twentyDayClose":25.55,"sixtyDayClose":37.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTHS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"PTHS","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"盤前","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-5.3},{"market":"US","date":"2025-07-02","symbol":"PTHS","defaultRemindTime":1751463000000,"type":"split","dateTimestamp":1751428800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTHS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTHS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1764997200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTHS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTHS","date":"2026-02-09","current":-1.127384,"percent":0.697368,"low":-12.702408,"twenty":-10.713209,"median":-3.468719,"eighty":-1.927869,"high":-1.189404,"avg":-5.564245,"sd":3.856389,"marketCap":70962796},"quantilePoints":[{"date":"2025-07-03","current":-1.450338,"twenty":-1.398151,"median":-1.319871,"eighty":-1.241591,"marketCap":10675383},{"date":"2025-07-11","current":-2.372872,"twenty":-2.216593,"median":-1.475876,"eighty":-1.450338,"marketCap":17465810},{"date":"2025-07-18","current":-1.983069,"twenty":-1.968731,"median":-1.794665,"eighty":-1.455446,"marketCap":14596616},{"date":"2025-07-25","current":-1.97142,"twenty":-1.96909,"median":-1.819083,"eighty":-1.509032,"marketCap":14510870},{"date":"2025-08-01","current":-1.895251,"twenty":-1.972137,"median":-1.894355,"eighty":-1.668896,"marketCap":13950222},{"date":"2025-08-08","current":-1.785927,"twenty":-1.971241,"median":-1.88181,"eighty":-1.778579,"marketCap":13145529},{"date":"2025-08-15","current":-1.383693,"twenty":-1.968373,"median":-1.828044,"eighty":-1.653842,"marketCap":12505731},{"date":"2025-08-22","current":-1.565412,"twenty":-1.958336,"median":-1.793992,"eighty":-1.534031,"marketCap":14148098},{"date":"2025-08-29","current":-7.738365,"twenty":-1.968373,"median":-1.78996,"eighty":-1.553735,"marketCap":69938867},{"date":"2025-09-05","current":-10.936036,"twenty":-1.983069,"median":-1.813483,"eighty":-1.562493,"marketCap":98839226},{"date":"2025-09-12","current":-10.771103,"twenty":-7.559968,"median":-1.868816,"eighty":-1.565412,"marketCap":97348576},{"date":"2025-09-19","current":-11.212045,"twenty":-9.357396,"median":-1.887634,"eighty":-1.641655,"marketCap":101333783},{"date":"2025-09-26","current":-11.188484,"twenty":-10.771103,"median":-1.911381,"eighty":-1.642041,"marketCap":101120833},{"date":"2025-10-03","current":-8.961188,"twenty":-10.771103,"median":-1.965147,"eighty":-1.648609,"marketCap":80990668},{"date":"2025-10-10","current":-8.414925,"twenty":-10.626367,"median":-1.972316,"eighty":-1.659169,"marketCap":76053575},{"date":"2025-10-17","current":-9.593014,"twenty":-10.434506,"median":-2.154672,"eighty":-1.70259,"marketCap":86701075},{"date":"2025-10-24","current":-11.663085,"twenty":-10.626367,"median":-7.559968,"eighty":-1.70259,"marketCap":105410254},{"date":"2025-10-31","current":-11.19185,"twenty":-10.777835,"median":-7.80905,"eighty":-1.706174,"marketCap":101151254},{"date":"2025-11-07","current":-12.702408,"twenty":-10.936036,"median":-7.98408,"eighty":-1.777862,"marketCap":114803587},{"date":"2025-11-14","current":-11.772301,"twenty":-11.111066,"median":-8.995487,"eighty":-1.781447,"marketCap":106397338},{"date":"2025-11-21","current":-3.765213,"twenty":-11.111066,"median":-8.414925,"eighty":-1.785927,"marketCap":88788749},{"date":"2025-11-28","current":-3.687312,"twenty":-11.108373,"median":-7.960687,"eighty":-1.792379,"marketCap":86951740},{"date":"2025-12-05","current":-3.422448,"twenty":-11.024224,"median":-7.763609,"eighty":-1.805104,"marketCap":80705911},{"date":"2025-12-12","current":-3.133628,"twenty":-10.952193,"median":-4.332389,"eighty":-1.816843,"marketCap":73895143},{"date":"2025-12-19","current":-2.967391,"twenty":-10.936709,"median":-3.83078,"eighty":-1.833421,"marketCap":69975058},{"date":"2025-12-26","current":-3.468719,"twenty":-10.936036,"median":-3.687312,"eighty":-1.856092,"marketCap":81797046},{"date":"2026-01-02","current":-4.057747,"twenty":-10.93065,"median":-3.642809,"eighty":-1.874014,"marketCap":95687111},{"date":"2026-01-09","current":-3.672916,"twenty":-10.883527,"median":-3.665062,"eighty":-1.88181,"marketCap":86612268},{"date":"2026-01-16","current":-3.395418,"twenty":-10.806109,"median":-3.583058,"eighty":-1.88647,"marketCap":80068505},{"date":"2026-01-23","current":-3.187295,"twenty":-10.776489,"median":-3.555764,"eighty":-1.893817,"marketCap":75160682},{"date":"2026-01-30","current":-3.374475,"twenty":-10.771103,"median":-3.506679,"eighty":-1.898477,"marketCap":79574636},{"date":"2026-02-06","current":-3.052604,"twenty":-10.742156,"median":-3.468719,"eighty":-1.919625,"marketCap":71984487},{"date":"2026-02-09","current":-3.009278,"twenty":-10.713209,"median":-3.468719,"eighty":-1.927869,"marketCap":70962796}],"updateTime":1770740562506},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTHS\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1188848364","title":"Pelthos Therapeutics公司孖展將用於支持Zelsuvmi商業化，並推動Xepi與Xeglyze上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1188848364","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188848364?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 21:34","pubTimestamp":1768311298,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics Inc. 近期成功获得融资，其募集资金将主要用于加速其核心产品Zelsuvmi的商业化进程。与此同时，公司也计划利用这笔资金正式推出另外两款重要产品——Xepi和Xeglyze，以进一步拓展其产品管线并巩固其在治疗领域的市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4135","HRZN","PTHS"],"gpt_icon":0},{"id":"2601833250","title":"Pelthos Therapeutics Inc.盤中異動 大幅上漲5.69%報29.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601833250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601833250?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 03:43","pubTimestamp":1767815022,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日03时43分，Pelthos Therapeutics Inc.股票出现异动，股价快速上涨5.69%。截至发稿，该股报29.00美元/股，成交量6264股，换手率0.20%，振幅3.86%。Pelthos Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为2.04%。Pelthos Therapeutics Inc.公司简介：Pelthos Therapeutics Inc是一家临床阶段的生物技术公司，开发和商业化新型，非阿片类，非成瘾性治疗来减轻疼痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010803434297a13597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010803434297a13597&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4539","BK4139","PTHS"],"gpt_icon":0},{"id":"1198778700","title":"Pelthos Therapeutics 簽署重要的藥品福利管理協議 擴大患者對 Zelsuvmi™ (Berdazimer) 外用凝膠的獲取","url":"https://stock-news.laohu8.com/highlight/detail?id=1198778700","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198778700?lang=zh_tw&edition=fundamental","pubTime":"2025-12-04 20:01","pubTimestamp":1764849670,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics 签署重要的药品福利管理协议，扩大患者对 Zelsuvmi™ (Berdazimer) 外用凝胶的获取，10.3%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"gpt_icon":0},{"id":"2582381023","title":"佩爾索斯治療公司獲得Xepi乳膏在美國的獨家營銷權Pelthos Therapeutics Secures Exclusive U.S. Marketing Rights for Xepi Cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2582381023","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582381023?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 18:09","pubTimestamp":1762769340,"startTime":"0","endTime":"0","summary":"此协议授予Pelthos在美国境内对Xepi的分销和商业化的控制权。Xepi Cream, which contains 1% ozenoxacin, is used as an antimicrobial treatment for skin infections. The acquisition involves transferring marketing rights from Biofrontera and Ferrer to Pelthos Therapeutics, allowing the company to oversee its availability and promotion across the country.含有1%奥泽诺沙星的Xepi乳膏被用作皮肤感染的抗菌治疗。此次收购涉及将Xepi的营销权从Biofrontera和Ferrer转移至Pelthos Therapeutics，使该公司能够在全国范围内监督其供应与推广。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111018112494fb2a80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111018112494fb2a80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PTHS","BK4139","BK4539","BK4007"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PTHS\",params:#limit:6,delay:false,,,undefined,":[]}}